News

On behalf of those impacted by Alzheimer’s disease, the Alzheimer’s Association enthusiastically welcomes today’s historic FDA approval of aducanumab (Biogen/Eisai) for the treatment of [...]

The FDA’s approval of the Biogen-Eisai drug, aducanumab, marks a milestone achievement in Alzheimer’s disease research. This drug is the first approved treatment shown to slow the progression of [...]

Tony Bennett has Alzheimer's disease, the most common form of age-related dementia. Alzheimer's is characterized by a progressive memory loss that robs its sufferers of many of the gifts that we [...]

Dr. Anthony Fauci talked about the importance of the COVID-19 vaccine as it relates to persons with dementia during a January 25 meeting of the National Alzheimer’s Project Act (NAPA) Advisory [...]

The next meeting of the Advisory Council on Alzheimer's Research, Care, and Services will be held on January 25, 2021, from 1:00pm to 4:30pm EST. The meeting, due to COVID-19, will be virtual and [...]

Final recommendations on ways to reduce disparities in dementia, which were developed during a stakeholder roundtable sponsored by the Milken Institute Alliance to Improve Dementia Care, will be [...]

No one knows why these diseases start in specific regions of the brain but we think it is influenced by the normal organization of brain networks,” said Bradford Dickerson, a behavioral [...]

The first-ever commercial Alzheimer’s blood test is on the market. It’s big progress. Some experts have reservations because it hasn’t yet secured FDA approval, among other limitations. While [...]

When Kate Sieloff’s husband, Karl, began acting strange, she didn’t know where to turn. Her hard-working, affectionate spouse was suddenly having fits of anger and aggression. He stopped paying [...]